Of course. Aptamers, often called “chemical antibodies,” are single-stranded DNA or RNA oligonucleotides that bind to specific targets with high affinity and specificity. Their unique properties—including in vitro selection (SELEX), chemical stability, low immunogenicity, and ease of modification—make them versatile tools across numerous fields.
Here are the major application fields of aptamers, categorized for clarity:
This is one of the most active areas, with one approved drug (Macugen® for macular degeneration) and many in clinical trials.
Antagonistic Therapeutics: Blocking the function of disease-related proteins (e.g., receptors, cytokines).
Targeted Drug Delivery: Aptamers are conjugated to drugs, toxins, or nanoparticles to selectively deliver them to diseased cells (e.g., cancer cells), minimizing systemic side effects.
Agonistic Therapeutics: Activating specific receptors to trigger therapeutic pathways.
Antiviral/Antibacterial Agents: Binding to viral surface proteins or bacterial toxins to neutralize them.
Aptamers are core components of novel, rapid, and sensitive diagnostic platforms.
Point-of-Care (POC) Tests: Used in lateral flow assays (like advanced pregnancy tests) for detecting pathogens (e.g., SARS-CoV-2), toxins, or biomarkers.
Electrochemical and Optical Biosensors: Aptamers immobilized on electrodes or chips change signals upon target binding, enabling detection of targets from small molecules to whole cells.
Medical Imaging: Radiolabeled or fluorescently labeled aptamers (optamers) act as contrast agents to visualize tumors or plaques in vivo.
Aptamers are indispensable tools in basic and applied research.
Cell Isolation and Sorting: Aptamers specific to cell-surface markers (e.g., on stem cells or cancer cells) are used for fluorescence-activated cell sorting (FACS) or magnetic separation.
Protein Detection and Quantification: Replace antibodies in techniques like ELISA (aptamer-based assays are called ELONA) or Western blotting.
Regulatory Function Studies: Used to inhibit or modulate specific proteins in cellular pathways to study their function.
Detection of Contaminants: Developing sensors for pesticides, heavy metals, antibiotics, and toxins (e.g., aflatoxin) in water and food.
Pathogen Detection: Rapid identification of foodborne pathogens like E. coli or Salmonella.
Aptazymes: Allosteric ribozymes whose activity is controlled by an aptamer domain, used as genetic switches or biosensors.
Controlled Gene Expression: Aptamer-based riboswitches regulate gene expression in response to small molecules in engineered circuits.
Directing Nanomaterial Assembly: Aptamers control the organization of nanoparticles into larger structures.
Functionalizing Surfaces: Creating “smart” surfaces that selectively capture or release targets (e.g., for targeted drug delivery or bioseparation).
In vitro Synthesis: No need for animals or cellular systems; selection can be done against toxins or non-immunogenic targets.
Stability: More thermally stable and can be renatured after denaturation.
Modifiability: Can be easily chemically modified and labeled at precise positions.
Small Size: Better tissue penetration in imaging and therapy.
Lower Batch-to-Batch Variation.
While promising, challenges remain, such as nuclease degradation (for RNA aptamers), rapid renal clearance in therapy, and the need for more efficient selection methods. Future directions focus on:
Developing better stabilization chemistries (e.g., 2′-fluoro, LNA modifications).
Creating novel SELEX strategies for complex targets like cell membranes.
Integrating aptamers with advanced platforms like CRISPR-based diagnostics, microfluidics, and wearable sensors.
In summary, aptamers are a transformative class of molecules bridging biotechnology, medicine, and engineering. Their application spectrum is continuously expanding, driven by their versatility and the growing need for precise, cost-effective molecular recognition tools.
Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer
Aptamer Screening- Current Methods and Future Trend towards Non-SELEX Approach
Aptamer Discovery Platform
Aptamer Screening Services for Peptide
selexkmdbio-Cell Nucleic Acid Aptamer Screening Service
Current Status and Future Directions of Aptamer Development
Key Characteristics and Working Principle of Aptamers
aptamer
Aptamer screening via SELEX for molecular recognition
APTAMER SCREENING METHODS
Aptamer screening technologies
EXPERTISE IN APTAMERS TO SMALL MOLECULES: A Practical Knowledge Guide to Selection, Engineering, and Real-World Performance
Toggle-SELEX Aptamer Screening Service
Negative Aptamer Selection- A Practical Guide to Improving Aptamer Specificity in SELEX
selexkmdbio-Cell Nucleic Acid Aptamer Screening Service
Aptamer Screening- Current Methods and Future Trend towards Non-SELEX Approach
Aptamer Screening Service-Subtractive SELEX
Aptamer Screening Service-Counter SELEX
Aptamer Screening Service-HT-SELEX
Aptamer Screening Service-NGS-SELEX
Aptamer Screening Service-Multi-Round SELEX Screening
Whole Cell-SELEX Aptamer Screening Service
Membrane Protein Aptamer Screening Service
Aptamer Screening Service for Drug Discovery
Aptamer Live Cell SELEX Service
Classical SELEX Service for Aptamer
Aptamer Selection and Identification
Aptamer Screening Process and Applications Overview